Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000864010 | SCV001004751 | likely benign | Myofibrillar myopathy 4 | 2024-12-22 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001171122 | SCV001333802 | likely benign | Cardiomyopathy | 2019-04-24 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001585812 | SCV001813321 | likely benign | not provided | 2019-04-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002345959 | SCV002649061 | likely benign | Cardiovascular phenotype | 2020-12-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |